<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11612">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00559013</url>
  </required_header>
  <id_info>
    <org_study_id>CP1011, Rev C</org_study_id>
    <nct_id>NCT00559013</nct_id>
  </id_info>
  <brief_title>Peri-Strips Dry (PSD) Veritas Collagen Matrix Staple Line Reinforcement for Colorectal Surgery</brief_title>
  <official_title>Peri-Strips Dry With Veritas Collagen Matrix Staple Line Reinforcement for Colorectal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Synovis Surgical Innovations</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Synovis Surgical Innovations</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose of the study is to assess the utility of PSD Veritas as a staple line reinforcement
      to minimize the risk of leakage during or after colo-rectal surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study is designed as a prospective enrollment of patients undergoing open or laparoscopic
      colorectal surgery requiring the creation of an anastomosis. Patients who are scheduled for
      elective resection of the left, anterior and low anterior colon can be enrolled in the
      study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Number of Participants With Major Colorectal Related Adverse Events: Leak, Stricture and Hemorrhage.</measure>
    <time_frame>Discharge and 1 Month post surgery</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">38</enrollment>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>PSD Veritas Collagen Matrix Reinforcement Arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Staple line reinforcement</intervention_name>
    <description>Placement of reinforcement material on circular anastomotic staple line for prevention of leak during and post surgery.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient must comply with follow-up evaluations

          -  Patient or representative must provide informed consent prior to enrollment

          -  Patient scheduled for elective surgical excision of the left, anterior or low
             anterior colon

          -  Patient must meet all criteria and be eligible to have open or laparoscopic
             colorectal surgery with primary anastomosis at one location

        Exclusion Criteria:

          -  Crohns disease

          -  Emergency colorectal surgery for trauma, obstruction, ischemic bowel, perforated
             diverticulum and all other emergent diagnosis.

          -  Patients who have not had mechanical bowel preparation

          -  Patients with known documented sensitivity/allergy to bovine material

          -  Severe radiation damage to tissue

          -  Carcinomatosis or stage IV cancer

          -  BMI is 35 or greater

          -  Cancer at primary anastomosis site that cannot be excised

          -  Patients who require an ileo rectal anastomosis

          -  Surgery anticipated to include jejunostomy pouch

          -  Anticipated diverting stoma

          -  No anti adhesive barrier can be used around anastomotic site

          -  No multiple circular anastomosis

          -  Surgeons discretion to exclude any patient he/she feels would not have a safe
             anastomosis

          -  Patient life expectacny less than follow-up timeframe of study

          -  Pregnancy

          -  Patients currently enrolled in a study that competes for the same patient population
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Karulf, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Colon &amp; Rectal Surgery Associates</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lahey Clinic</name>
      <address>
        <city>Burlington</city>
        <state>Massachusetts</state>
        <zip>01805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Colon &amp; Rectal Surgery Associates</name>
      <address>
        <city>St. Paul</city>
        <state>Minnesota</state>
        <zip>55105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <lastchanged_date>May 23, 2012</lastchanged_date>
  <firstreceived_date>November 14, 2007</firstreceived_date>
  <firstreceived_results_date>December 15, 2009</firstreceived_results_date>
  <responsible_party>
    <name_title>Lesa Hobright-Turner, Director of Clinical Affairs</name_title>
    <organization>Synovis Surgical Innovations</organization>
  </responsible_party>
  <keyword>Staple line reinforcement</keyword>
  <keyword>Staple line buttress</keyword>
  <keyword>Anastomotic reinforcement</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>

  <clinical_results>

    <participant_flow>
      <recruitment_details>38 subjects were recruited from two principal investigators and their respective surgical hospitals in the US from approximately February 2007 through October 2008.</recruitment_details>
      <pre_assignment_details>Subjects were excluded from the study if the met any of the exclusion criteria including having a a body mass index greater than 35, a history of Chron's Disease, or stage IV cancer. There was no washout, run-in or transition period to this study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>PSD Veritas Collagen Matrix Reinforcement Arm</title>
          <description>Subjects receiving PSD Veritas Collagen Matrix for staple line reinforcement when undergoing open or laparoscopic colorectal surgery requiring the creation of an anastomosis.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>PSD Veritas Collagen Matrix Reinforcement Arm</title>
          <description>Subjects receiving PSD Veritas Collagen Matrix for staple line reinforcement when undergoing open or laparoscopic colorectal surgery requiring the creation of an anastomosis.</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="38"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="27"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="11"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="57.26" spread="11.44"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="18"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="20"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>United States</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="38"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Major Colorectal Related Adverse Events: Leak, Stricture and Hemorrhage.</title>
        <time_frame>Discharge and 1 Month post surgery</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>PSD Veritas Collagen Matrix Reinforcement Arm</title>
            <description>Subjects receiving PSD Veritas Collagen Matrix for staple line reinforcement when undergoing open or laparoscopic colorectal surgery requiring the creation of an anastomosis.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="38"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Number of Participants With Major Colorectal Related Adverse Events: Leak, Stricture and Hemorrhage.</title>
            <units>Participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="4"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>PSD Veritas Collagen Matrix Reinforcement Arm</title>
          <description>Subjects receiving PSD Veritas Collagen Matrix for staple line reinforcement when undergoing open or laparoscopic colorectal surgery requiring the creation of an anastomosis.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Anastomotic Buttress Leak</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="38"/>
              </event>
              <event>
                <sub_title>Bleeding</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Post operative ileus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Lesa Hobright-Turner, Director of Clinical Affairs</name_or_title>
      <organization>Synovis</organization>
      <phone>651-796-7506</phone>
      <email>lesa.hobrightturner@synovissurgical.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
